Header Logo

Connection

MICHAEL WHITE to Drug Screening Assays, Antitumor

Back to Details
This is a "connection" page, showing publications MICHAEL WHITE has written about Drug Screening Assays, Antitumor.
MICHAEL WHITE
Connection Strength
0.035
Drug Screening Assays, Antitumor
  1. A Functional Signature Ontology (FUSION) screen detects an AMPK inhibitor with selective toxicity toward human colon tumor cells. Sci Rep. 2018 02 28; 8(1):3770.
    View in: PubMed
    Score: 0.035
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.